2 completed, 2 not yet recruiting, 2 recruiting, 1 terminated. 5 Phase 1, 2 Phase 2.
By phase and status
Follow BMS-986368: new trials by email Literature Review of BMS-986368 trials Research Report on BMS-986368
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants
BMS-986368, BMS-986368-matching Placebo - Healthy Volunteers | Phase 1 | Not yet recruiting | 16 | 2027-01-05 | 2026-07-14 |
A Study to Assess the Relative Bioavailability of Irafamdastat (BMS-986368) and to Assess the Food Effect on the Pharmacokinetics of Irafamdastat in Healthy Adult Participants
Irafamdastat - Healthy Volunteers | Phase 1 | Not yet recruiting | 24 | 2026-10-06 | 2026-09-23 |
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
BMS-986368, Placebo - Agitation, Alzheimer Disease | Phase 2 | Recruiting | 120 | 2025-06-09 | 2026-10-06 |
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
BMS-986368, Placebo - Multiple Sclerosis Spasticity | Phase 2 | Recruiting | 200 | 2025-06-05 | 2026-10-27 |
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity
BMS-986368 - Healthy Participants | Phase 1 | Completed | 56 | 2024-05-31 | 2024-11-12 |
A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
BMS-986368, Itraconazole, Famotidine - Healthy Participants | Phase 1 | Completed | 32 | 2024-03-18 | 2024-07-01 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
CC-97489, Placebo - Healthy Volunteers | Phase 1 | Terminated | 84 | 2020-03-13 | 2023-12-14 |
Conditions studied
Alzheimer Disease (1) · Multiple Sclerosis (1) · Muscle Spasticity (1) · Psychomotor Agitation (1)
Sponsors
Celgene (7)
Countries
United States (5) · Australia (2) · Argentina (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Germany (1) · Poland (1) · Puerto Rico (1)
NIH funding
2019 (1)